Kidney Int October 2020 PMID 32998798

KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

Full text PDF Download social card

Mentions

128

Peak: 37 in Oct 2021

across 5 sources since Sep 2020

Extended reach

995,353

potential audience

Total likes

807

Video views

45,198

Mentions per month

Sep 2020 – Aug 2023

Where it's discussed

X / Twitter112 posts
News8 articles
YouTube3 videos
Blogs3 articles
Facebook2 posts

AI synopsis

What people are saying

Several posts highlight the KDIGO 2020 guidelines, with expressions of appreciation for their actionable recommendations, such as managing HbA1c levels in CKD patients. The tone often conveys enthusiasm, using terms like 'great graphic' and 'must consider,' which underscores the perceived importance of the guidelines in evolving clinical practices.

AgreementModerate agreement

Most discussions reference the guidelines positively, suggesting general support among participants.

InterestHigh interest

The frequency of posts indicates a high level of curiosity and relevance to recent discussions in the medical community.

EngagementModerate engagement

While some posts were more informational, a few demonstrated deeper engagement with the material through references to specific findings.

ImpactHigh impact

Many users regard the guidelines as having a significant influence on diabetes management practices, emphasizing actionable recommendations.

Abstract in brief

It emphasizes the importance of early screening and consistent monitoring of kidney function in diabetic patients to prevent progression of kidney disease.
The guidelines recommend individualized treatment plans that include lifestyle modifications, glucose control, and consideration of medications that are kidney-friendly.
It stresses the need for a multidisciplinary approach in managing patients, involving healthcare providers like dietitians and nephrologists for comprehensive care.

Read the full abstract

All mentions

SGLT2 Inhibitors for Kidney Disease: Clinical Insights and Benefits

This Harvard Medical School Continuing Education video explores how SGLT2 inhibitors like canagliflozin and dapagliflozin protect the kidneys, review key trial findings, and discuss updated guidelines, highlighting…

Harvard Medical School Continuing Education · Apr 7, 2022 41,298 views

Nephrology Insights 2022: New Treatments for Chronic Kidney Disease

Professor Marcus Säemann and colleagues discuss four emerging substances that will transform treatment strategies for patients with diabetic kidney disease, lupus, and ANCA-associated vasculitis. Finerenone, a notable…

MARKUS at HOMe · Jan 14, 2022 2,478 views

Understanding Quantum Entanglement and Its Implications

This video explores the concept of quantum entanglement, discussing its fundamental principles and significant implications in quantum physics. Understand how entangled particles communicate instantaneously, regardless…

Dica Médica · Aug 25, 2023 1,422 views

David Montoro Cremades

@davidpodologia · X

Revisando el artículo "Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022" (Hahr & Molitch, 2022), he econtrado esta figura, perteneciente a la "KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease". https://t.co/nhPEAXwkK3

Jan 26, 2023 · 2 likes · 18 followers View post →

Diego Segura-Rodríguez

@SeguraCardio · X

@Miguel_A_Maria KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease https://t.co/ewdStRddKi Saludos https://t.co/S9AQyyLOGr

Oct 17, 2022 · 25,727 followers View post →

NarjesN27628538

@NarjesN27628538 · X

RT @Nader_AlSheraim: علاج NSTEMI-ACS من ESC https://t.co/hQPbXbbqur علاج Asthma من NAEPP https://t.co/0TuPzWbBfq علاج هشاشة العظام بعد سن…

Jun 11, 2022 · 11 shares · 14 followers View post →

Dr. Oriba Dan Langoya

@DrOribaDan · X